Included in the group of poor prognosis

Included in the group of poor prognosis. The latter also includes all patients with disease resistance3. current treatment The daily citarabene regimen for 7 days and เลือดdonorubicin for the first 3 days was considered the most adequate induced treatment program. for combined therapy and treatment It takes the same course as induction therapy. Special attention should be given to the treatment of acute promyelocyte leukemia. One of the most important discoveries in the field of hematology.